Shorted
Epsilon Healthcare logo
EPN
Pharmaceuticals, Biotechnology & Life Sciences

Epsilon Healthcare

Short interest
0.01%
+0.01 pp 30d
as of 5 June 2023
Reported shorts
22.2K
Shares on issue
300.354M

Epsilon Healthcare (EPN) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
8 Oct

What Does Epsilon Healthcare (ASX:EPN) Gain From Helix?

Highlights Epsilon will manufacture a nanoemulsion cannabinoid platform for Helix. A New Zealand grower will supply botanical feedstock. Early-stage science and thin funding keep the risk profile high. Epsilon Healthcare (ASX:EPN) has agreed a tie-up with a pair of partners to develop and manufacture cannabinoid medicines, casting its Queensland facility as the exclusive global manufacturing partner for a nanoemulsion delivery technology owned by Helix Research Australia. The announcement, ma...

Continue reading
Kalkine
Neutral
28 Sept

Why is Epsilon Healthcare (ASX:EPN) scaling cannabis output?

Highlights Epsilon Healthcare is closing its first quarter since posting record customer receipts across its manufacturing, clinic and pharmacy arms. A renewed medicinal cannabis manufacturing permit now allows substantially higher production at its Southport facility. Tight cash, related-party funding and a governance dispute sit alongside the growth story and deserve close attention. Epsilon Healthcare (ASX:EPN) reaches the end of its September quarter this week with its onshore medicinal c...

Continue reading
Kalkine
Neutral
17 Sept

What Does Epsilon Healthcare (ASX:EPN) Mean for Penny Stocks?

Highlights Epsilon Healthcare (ASX:EPN) is involved in the manufacture and distribution of medicinal cannabis products. Its smaller market position places it among the names tracked within Penny Stocks. Prescribing trends and regulatory settings continue to shape its outlook. Manufacturing and distribution capability plays an important role within Australia's medicinal cannabis supply chain, and Epsilon Healthcare (ASX:EPN) occupies that position among smaller names tracked within the Penny S...

Continue reading
Kalkine
Neutral
17 Sept

Why Is Epsilon Healthcare (ASX:EPN) Back in Focus Today?

Highlights Epsilon Healthcare (ASX:EPN) is involved in the manufacture and distribution of medicinal cannabis products. The company operates within Australia's regulated medicinal cannabis supply chain. Prescribing trends and regulatory settings continue to shape its outlook. Within Australia's medicinal cannabis supply chain, distribution and manufacturing capability matter just as much as cultivation, and that is where Epsilon Healthcare (ASX:EPN) fits in. Positioned within the Cannabis Sto...

Continue reading
Kalkine
Neutral
17 Sept

Epsilon Healthcare Director Zoe Hutchings Purchases 358,491 Shares in On-Market Transaction

Epsilon Healthcare Limited (ASX:EPN) announced a change in director Zoe Hutchings' relevant interests after she acquired 358,491 fully paid ordinary shares through an on-market purchase on 10 September 2026, as detailed in a Change of Director's Interest Notice filed with the ASX. Key Points Director Zoe Hutchings bought 358,491 fully paid ordinary shares in Epsilon Healthcare on 10 September 2026. The on-market acquisition cost a total of $9,699.21, inclusive of brokerage fees. Before the tr...

Continue reading
Kalkine
Neutral
15 Sept

Why Could Epsilon Healthcare (ASX:EPN) Face a Balance-Sheet Test?

Highlights Epsilon Healthcare enters September with balance-sheet quality becoming an increasingly important consideration for smaller ASX companies. Its healthcare and medicinal-cannabis services operations give the company exposure to a specialised and evolving part of the Australian healthcare market. The broader ASX backdrop remains sensitive to energy costs, bond yields and uneven sector leadership, placing greater emphasis on company-specific developments. The Australian share mark...

Continue reading